We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis.
- Authors
Pelfrene, Eric; Harvey Allchurch, Martin; Ntamabyaliro, Nsengi; Nambasa, Victoria; Ventura, Fátima V.; Nagercoil, Nithyanandan; Cavaleri, Marco
- Abstract
The article discusses the European Medicines Agency‘s scientific Committee for Medicinal Products for Human Use's (CHMP) opinion on treatment of human African trypanosomiasis (HAT) or sleeping sickness with oral administration of fexinidazole tablets. It stats that the CHMP opinion aimed at evaluation of benefit-risk for medicines relevant to populations outside the European Union.
- Subjects
AFRICAN trypanosomiasis; THERAPEUTICS; EUROPEAN Medicines Agency; NITROIMIDAZOLES
- Publication
PLoS Neglected Tropical Diseases, 2019, Vol 13, Issue 6, p1
- ISSN
1935-2727
- Publication type
Article
- DOI
10.1371/journal.pntd.0007381